Basic Information
Basic information for SNHG14-269-63aa-3
Peptide Name SNHG14-269-63aa-3
Genome Position chr15:25121579-25121767[+]
Species Human
Peptide Sequence MLILSAKYFVYHVRKVCHLLSFLRNFNQNQVVDIIKLFCRINFPVLFKDFYHCELIYYYCNFL
Peptide Length 63
Unique No (SNHG14-210-63aa-2,SNHG14-224-63aa-1,SNHG14-227-63aa-2,SNHG14-230-63aa-1,SNHG14-231-63aa-2,SNHG14-232-63aa-2,SNHG14-235-63aa-2,SNHG14-239-63aa-2,SNHG14-242-63aa-2,SNHG14-249-63aa-2,SNHG14-251-63aa-2,SNHG14-254-63aa-2,SNHG14-255-63aa-2,SNHG14-257-63aa-1,SNHG14-268-63aa-2,SNHG14-270-63aa-1,SNHG14-274-63aa-2,SNHG14-275-63aa-1,SNHG14-276-63aa-2,SNHG14-277-63aa-2,SNHG14-278-63aa-2,SNHG14-279-63aa-2,SNHG14-280-63aa-1,SNHG14-281-63aa-2,SNHG14-282-63aa-3,SNHG14-283-63aa-2,SNHG14-287-63aa-1,SNHG14-288-63aa-1,SNHG14-293-63aa-2,SNHG14-298-63aa-2,SNHG14-300-63aa-2,SNHG14-301-63aa-1,SNHG14-304-63aa-2,SNHG14-309-63aa-1,SNHG14-311-63aa-2,SNHG14-312-63aa-1,SNHG14-313-63aa-2,SNHG14-314-63aa-2,SNHG14-322-63aa-2,SNHG14-323-63aa-2,SNHG14-324-63aa-2,SNHG14-325-63aa-2,SNHG14-330-63aa-2,SNHG14-332-63aa-2,SNHG14-333-63aa-2,SNHG14-334-63aa-1,SNHG14-335-63aa-2,SNHG14-338-63aa-2,SNHG14-340-63aa-2)
Grand Average of Hydropathicity 0.5286
Relative Molecular Mass 8935.26
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000660717;SNHG14-269
Transcript Length 11055
Coding Ability 0.4123
DNA Sequence Corresponding to Peptide ATGCTGATTTTAAGTGCGAAATACTTTGTCTACCATGTTAGGAAAGTCTGCCACCTTTTATCTTTTTTAAGGAATTTTAATCAAAACCAGGTGGTAGATATAATCAAATTGTTTTGCAGAATCAATTTTCCTGTTCTCTTTAAAGACTTTTATCACTGTGAATTAATTTACTATTATTGCAACTTCCTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :